ArticleEuropean urology2024

Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.

Chung-Han Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.